StocktradeC

ABBV long setup

做多
NYSE:ABBV   AbbVie Inc.
ABBV’s innovation outlook is trending up based on a current score of 70 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is positive. ABBV is an Outperformer in terms of sustainability. It is most exposed to AstraZeneca PLC as its supplier. Over the past 4 quarters ABBV beat earnings estimates 3 times and it pays dividend higher than its peers.
For more analysis and articles visit our website.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。